Compile Data Set for Download or QSAR
Report error Found 940 Enz. Inhib. hit(s) with all data for entry = 3017
TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388508(US9944618, Compound ID No. 42)
Affinity DataKi:  0.300nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388484(US9944618, Compound ID No. 18)
Affinity DataKi:  0.400nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388637(US9944618, Compound ID No. 173 | AZD1858 MCJ001- S...)
Affinity DataKi:  0.5nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388469(US9944618, Compound ID No. 3)
Affinity DataKi:  0.600nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388467(US9944618, Compound ID No. 1)
Affinity DataKi:  0.700nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388533(US9944618, Compound ID No. 67)
Affinity DataKi:  0.700nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388498(US9944618, Compound ID No. 32)
Affinity DataKi:  0.700nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM22416(PAROXETINE | CHEMBL490 | (3S,4R)-3-[(1,3-benzodiox...)
Affinity DataKi:  0.800nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388472(US9944618, Compound ID No. 6)
Affinity DataKi:  0.800nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388527(US9944618, Compound ID No. 61)
Affinity DataKi:  0.900nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388496(US9944618, Compound ID No. 30)
Affinity DataKi:  1nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388468(US9944618, Compound ID No. 90 | US9944618, Compoun...)
Affinity DataKi:  1nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388559(US9944618, Compound ID No. 93)
Affinity DataKi:  1.10nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388495(US9944618, Compound ID No. 29)
Affinity DataKi:  1.10nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388637(US9944618, Compound ID No. 173 | AZD1858 MCJ001- S...)
Affinity DataKi:  1.20nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM22417(LY 94939 | Nisoxetine Inhibitor | Nisoxetine | LY1...)
Affinity DataKi:  1.30nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388469(US9944618, Compound ID No. 3)
Affinity DataKi:  1.30nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388474(US9944618, Compound ID No. 8)
Affinity DataKi:  1.30nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388473(US9944618, Compound ID No. 7)
Affinity DataKi:  1.40nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388470(US9944618, Compound ID No. 4)
Affinity DataKi:  1.40nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388499(US9944618, Compound ID No. 33)
Affinity DataKi:  1.40nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388471(US9944618, Compound ID No. 5)
Affinity DataKi:  1.40nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388474(US9944618, Compound ID No. 8)
Affinity DataKi:  1.40nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388472(US9944618, Compound ID No. 6)
Affinity DataKi:  1.40nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388476(US9944618, Compound ID No. 10)
Affinity DataKi:  1.5nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388475(US9944618, Compound ID No. 9)
Affinity DataKi:  1.5nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388479(US9944618, Compound ID No. 13)
Affinity DataKi:  1.60nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388477(US9944618, Compound ID No. 11)
Affinity DataKi:  1.60nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388480(US9944618, Compound ID No. 14)
Affinity DataKi:  1.60nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388492(US9944618, Compound ID No. 26)
Affinity DataKi:  1.60nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388478(US9944618, Compound ID No. 12)
Affinity DataKi:  1.60nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388481(US9944618, Compound ID No. 15)
Affinity DataKi:  1.70nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388484(US9944618, Compound ID No. 18)
Affinity DataKi:  1.80nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388482(US9944618, Compound ID No. 16)
Affinity DataKi:  1.80nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388521(US9944618, Compound ID No. 55)
Affinity DataKi:  1.80nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388555(US9944618, Compound ID No. 89)
Affinity DataKi:  1.80nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388483(US9944618, Compound ID No. 36 | US9944618, Compoun...)
Affinity DataKi:  1.80nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM35229(Desmethylimipramine | 3-(10,11-dihydro-5H-dibenzo[...)
Affinity DataKi:  1.80nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388467(US9944618, Compound ID No. 1)
Affinity DataKi:  1.90nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388497(US9944618, Compound ID No. 31)
Affinity DataKi:  1.90nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388485(US9944618, Compound ID No. 19)
Affinity DataKi:  1.90nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388486(US9944618, Compound ID No. 20)
Affinity DataKi:  1.90nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388487(US9944618, Compound ID No. 21)
Affinity DataKi:  2nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388488(US9944618, Compound ID No. 22)
Affinity DataKi:  2nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388489(US9944618, Compound ID No. 23)
Affinity DataKi:  2nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388541(US9944618, Compound ID No. 75)
Affinity DataKi:  2.10nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388488(US9944618, Compound ID No. 22)
Affinity DataKi:  2.10nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388490(US9944618, Compound ID No. 24)
Affinity DataKi:  2.20nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388513(US9944618, Compound ID No. 47)
Affinity DataKi:  2.20nMAssay Description:SERT: This protocol was designed to measure inhibition of uptake by the human serotonin transporter. The reagents were human SERT (HEK293F) cells, fl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

TargetSodium-dependent noradrenaline transporter(Human)
Mayo Foundation

US Patent
LigandPNGBDBM388491(US9944618, Compound ID No. 25)
Affinity DataKi:  2.20nMAssay Description:NET: This protocol was designed to measure inhibition of uptake by the human norepinephrine transporter. The reagents were human NET (HEK293F) cells,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2020
Entry Details
US Patent

Displayed 1 to 50 (of 940 total ) | Next | Last >>
Jump to: